Article
Current perspectives on CHEK2 mutations in breast cancer
1 May 2017
Abstract excerpt
Checkpoint kinase 2 (CHEK2) is a serine/threonine kinase which is activated upon DNA damage and is implicated in pathways that govern DNA repair, cell cycle arrest or apoptosis in response to the initial damage. Loss of kinase function has been correlated with different types of cancer, mainly breast cancer. CHEK2 functionality is affected by different missense or deleterious mutations. CHEK2*1100delC and I157T...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
